On air · 1 of 3 networks
Neurocrine Biosciences
- neurocrine.com
- US
- 2,488 employees
Neurocrine Biosciences’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 26. Watch Neurocrine Biosciences with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 25 | Checked 29 Oct 2026 | See all 26 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 23 Oct 2026 | Collect them with the API → |
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 5 Oct 2026 | Collect them with the API → |
Neurocrine Biosciences has 25 live LinkedIn ads. Its Facebook page had no active ads on 23 Oct 2026, and we recorded no Google ads on 5 Oct 2026.
Latest ads
- LINKEDIN · JOBSince 13 Nov 2023
- LINKEDIN · FOLLOWRecorded 27 Sept 2026
Get the latest jobs and industry news
- LINKEDIN · IMAGERecorded 12 Oct 2026
October 10 marks #WorldMentalHealthDay, an important reminder of the role mental health and well-being play in our workplaces and communities. At Neurocrine, we’re committed to fostering a culture where employees feel supported, open conversations are encouraged and mental health is valued. This year we’re proud to have received Mental Health America's 2026 Gold Bell Seal for Workplace Mental Health in recognition of our efforts to support employee well-being. #MIAW #MentalHealth
- LINKEDIN · IMAGERecorded 12 Oct 2026
Today is National Depression Screening Day: an important reminder to check in on your mental health. Screening can be a first step toward recognizing potential symptoms and starting a conversation with a healthcare provider. Through our focus on psychiatry, we’re working to deepen our understanding of major depressive disorder and the needs of people living with this condition. #MIAW #MDD #Depression
- LINKEDIN · IMAGERecorded 12 Oct 2026
The broad range of symptoms associated with schizophrenia can place a significant burden on daily life. Limitations of current treatment options may affect patient outcomes, reinforcing the need for continued innovation. Learn more about Neurocrine’s research in schizophrenia.
- LINKEDIN · IMAGERecorded 12 Oct 2026
Many people living with major depressive disorder have tried multiple treatment options without finding a medication that addresses their symptoms. Explore Neurocrine’s ongoing research into approaches for major depressive disorder.
6 of 26 adsSign up to see every Neurocrine Biosciences ad, filter by format and date, and get alerts on new ones.
See all 26 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.